| Atg9 is required for intraluminal vesicles in amphisomes and autolysosomes CA Bader, T Shandala, YS Ng, IRD Johnson, DA Brooks Biology open 4 (11), 1345-1355, 2015 | 56 | 2015 |
| Fluorescence microscopy—an outline of hardware, biological handling, and fluorophore considerations SM Hickey, B Ung, C Bader, R Brooks, J Lazniewska, IRD Johnson, ... Cells 11 (1), 35, 2021 | 43 | 2021 |
| Altered endosome biogenesis in prostate cancer has biomarker potential IRD Johnson, EJ Parkinson-Lawrence, T Shandala, R Weigert, LM Butler, ... Molecular Cancer Research 12 (12), 1851-1862, 2014 | 43 | 2014 |
| Endosomal gene expression: a new indicator for prostate cancer patient prognosis? IRD Johnson, EJ Parkinson-Lawrence, H Keegan, CD Spillane, ... Oncotarget 6 (35), 37919, 2015 | 41 | 2015 |
| Lipid profiles of prostate cancer cells A Sorvina, CA Bader, C Caporale, EA Carter, IRD Johnson, ... Oncotarget 9 (85), 35541, 2018 | 38 | 2018 |
| Mitochondrial imaging in live or fixed tissues using a luminescent iridium complex A Sorvina, CA Bader, JRT Darby, MC Lock, JY Soo, IRD Johnson, ... Scientific reports 8 (1), 8191, 2018 | 38 | 2018 |
| Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion HK Armstrong, JL Gillis, IRD Johnson, ZD Nassar, M Moldovan, C Levrier, ... Scientific reports 8 (1), 2090, 2018 | 35 | 2018 |
| Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide W Zhang, S Garg, P Eldi, FH Zhou, IRD Johnson, DA Brooks, F Lam, ... International Journal of Pharmaceutics 513 (1-2), 270-279, 2016 | 29 | 2016 |
| Prostate cell lines as models for biomarker discovery: Performance of current markers and the search for new biomarkers IR Johnson, EJ Parkinson‐Lawrence, LM Butler, DA Brooks The Prostate 74 (5), 547-560, 2014 | 25 | 2014 |
| NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development IP Harrison, A Vinh, IRD Johnson, R Luong, GR Drummond, CG Sobey, ... Oncotarget 9 (83), 35378, 2018 | 24 | 2018 |
| Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer C Martini, JM Logan, A Sorvina, C Gordon, AR Beck, BSY Ung, ... Pathology 55 (1), 40-51, 2023 | 15 | 2023 |
| Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers GT Lam, S Prabhakaran, A Sorvina, C Martini, BSY Ung, L Karageorgos, ... Molecular Diagnosis & Therapy 27 (1), 49-60, 2023 | 9 | 2023 |
| A fluorescent and solvatochromic 1, 8-naphthalimide probe for detection of lipid droplet trafficking and biogenesis SM Hickey, IRD Johnson, E Dallerba, MJ Hackett, M Massi, J Lazniewska, ... Dyes and Pigments 217, 111382, 2023 | 7 | 2023 |
| Prediction of prostate cancer biochemical and clinical recurrence is improved by IHC-assisted grading using Appl1, Sortilin and Syndecan-1 JM Logan, AM Hopkins, C Martini, A Sorvina, P Tewari, S Prabhakaran, ... Cancers 15 (12), 3215, 2023 | 7 | 2023 |
| A 3, 4-dimethoxy-1, 8-naphthalimide for lipid droplet imaging in live and fixed cells IRD Johnson, EE Rudebeck, MJ Sweetman, A Sorvina, TD Ashton, ... Sensors and Actuators B: Chemical 365, 131921, 2022 | 6 | 2022 |
| Implications of altered endosome and lysosome biology in space environments IRD Johnson, CT Nguyen, P Wise, D Grimm International Journal of Molecular Sciences 21 (21), 8205, 2020 | 5 | 2020 |
| A paradigm in immunochemistry, revealed by monoclonal antibodies to spatially distinct epitopes on syntenin-1 IRD Johnson, A Sorvina, JM Logan, CR Moore, JK Heatlie, ... International Journal of Molecular Sciences 20 (23), 6035, 2019 | 5 | 2019 |
| Methods for detecting prostate cancer DA Brooks, EJ Parkinson-Lawrence, IRD Johnson, LM Butler, R Weigert WO Patent WO2014197937A1, 2014 | 4 | 2014 |
| Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread A Sorvina, C Martini, S Prabhakaran, JM Logan, BSY Ung, C Moore, ... Pathology 55 (6), 792-799, 2023 | 3 | 2023 |
| Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression J Lazniewska, KL Li, IRD Johnson, A Sorvina, JM Logan, C Martini, ... Scientific reports 13 (1), 13489, 2023 | 3 | 2023 |
